{"version":"1.0","provider_name":"Clario","provider_url":"https:\/\/clario.com","author_name":"Gary Norman","author_url":"https:\/\/clario.com\/author\/garyn\/","title":"Progressing Beyond Exploratory Endpoints: The Value of Digital Biomarkers in Neuroscience Clinical Studies Webinar Replay","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"JmwuBngYxX\"><a href=\"https:\/\/clario.com\/resources\/webinars\/progressing-beyond-exploratory-endpoints-the-value-of-digital-biomarkers-in-neuroscience-clinical-studies-webinar-replay\/\">Progressing Beyond Exploratory Endpoints: The Value of Digital Biomarkers in Neuroscience Clinical Studies Webinar Replay<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/clario.com\/resources\/webinars\/progressing-beyond-exploratory-endpoints-the-value-of-digital-biomarkers-in-neuroscience-clinical-studies-webinar-replay\/embed\/#?secret=JmwuBngYxX\" width=\"600\" height=\"338\" title=\"&#8220;Progressing Beyond Exploratory Endpoints: The Value of Digital Biomarkers in Neuroscience Clinical Studies Webinar Replay&#8221; &#8212; Clario\" data-secret=\"JmwuBngYxX\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"Learn how advances in eCOA, digital movement analysis, and medical imaging methodologies are shaping the future of neuroscience drug development. Digital biomarkers are revolutionizing neuroscience trials by transforming from exploratory tools into validated, impactful endpoints. Now available on-demand: Learn from this engaging webinar where our featured speakers present real-world examples and case studies on the","thumbnail_url":"https:\/\/clario.com\/wp-content\/uploads\/2021\/11\/Clario-Website-Open-Graph-Image.jpg","thumbnail_width":1200,"thumbnail_height":627}